Piedmont Capital Investments

Scout AI is building the robotic foundation model for defense.

MetOx Technologies is a manufacturer of high-temperature superconducting (HTS) wire, utilizing YBCO to facilitate the efficient transmission of electricity. This technology allows for the transmission of large amounts of electricity with minimal cross-sectional area, eliminating electrical loss and heat generation during operation. MetOx employs a proprietary one-pass metal-organic chemical vapor deposition process for the production of buffer and superconductor layers, enhancing the quality and cost-effectiveness of its HTS wire. The applications of this advanced wire include upgrading transmission and distribution lines, supporting magnetic confinement fusion reactors, and developing next-generation MRI scanners, as well as use in wind turbines.

Nzero is a carbon emissions tracking management platform established in 2017 and based in Carson City, Nevada. The platform operates continuously to capture and manage Scope 1, 2, and 3 emissions data with high accuracy. By utilizing customers' energy, water, and utility data alongside publicly-reported emissions and partner data, Nzero provides precise, actionable, and auditable insights. This enables organizations to take effective measures toward reducing their carbon footprint and achieving net-zero emissions. The platform also supports financial reporting, contract administration, decision-making, payments, and workflows through a user-friendly interface, helping companies meet their sustainability objectives and comply with regulatory requirements.

Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, that focuses on enhancing enterprise knowledge management. Founded in 2017 by Igor Jablokov, Pryon develops an augmented intelligence platform that combines human and machine capabilities to streamline access to information across various channels and sources. The platform employs natural language processing and automated machine learning to transform unstructured data into actionable insights, thereby boosting productivity and decision-making accuracy. By utilizing a no-code approach, Pryon enables organizations to quickly harness the value of their information assets without disrupting existing operations. The company's solutions aim to simplify AI adoption, reduce complexity, and lower costs for businesses seeking to improve their workflows and knowledge utilization.

Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer. The company was founded in 2019 and based in Durham, North Carolina.

Epirus, Inc. is a company focused on developing advanced defense technologies that utilize artificial intelligence and directed energy systems. Based in Hawthorne, California, it specializes in solid-state, software-defined high-power microwave systems designed to counter unmanned aircraft and other asymmetric threats. The company's flagship product, ELECTROMAGNETIC PULSE, functions as a drone countermeasure by delivering multiple beams simultaneously, effectively disrupting and neutralizing aerial threats. Additionally, Epirus employs AI and computer vision to enhance its capabilities in detecting and tracking various targets of interest. Founded in 2018, Epirus aims to provide innovative solutions for both national security and commercial applications, optimizing power management and efficiency in electronic warfare scenarios.

Posh is a conversational AI and NLP technology development company that enables developers to deliver a new way to interact with users. With Posh, website actions that takes minutes to complete can be sped up to just seconds with a simple message from bots. Companies in finanical services, healthcare, utilities, and beyond are using the Posh platform to re-create call centers and automate routine requests for both customers and staff while saving time and money. The company wants to make the internet experience easier and more enjoyable. Posh was launched on 2015 and is based in Boston, Massachusetts.

Immunai Inc. is a biotechnology company that specializes in immune profiling through its artificial intelligence-based platform, which combines single-cell genomics and machine learning. Founded in 2018 and headquartered in New York City, with additional offices in San Francisco and Tel Aviv, Immunai aims to map the immune system comprehensively. Its technology allows for high-resolution profiling of immune cells from blood samples, enabling the identification of numerous cell types and their states. This approach generates valuable biological insights that support drug development, particularly in oncology and autoimmune disorders. The company collaborates with academic institutions, biopharmaceutical firms, and biotechnology companies to drive research in areas such as cancer therapy and vaccines.

Tvardi Therapeutics, Inc. is a biotechnology company based in Houston, Texas, focused on developing innovative medicines for cancer, chronic inflammation, and fibrosis. Founded in 2017, the company specializes in small molecule inhibitors targeting STAT3, a regulatory protein involved in the progression of various cancers and fibrotic diseases. Tvardi's pipeline includes TTI-101, an oral small-molecule STAT3 inhibitor, and an intravenous formulation for non-cancer indications, as well as TTI-102, another oral candidate with potential in STAT3 inhibition. By addressing the underlying mechanisms of disease, Tvardi Therapeutics aims to provide effective treatments for patients suffering from diverse conditions, including breast and lung cancer, as well as chronic inflammatory and fibrotic diseases.

Epirus, Inc. is a company focused on developing advanced defense technologies that utilize artificial intelligence and directed energy systems. Based in Hawthorne, California, it specializes in solid-state, software-defined high-power microwave systems designed to counter unmanned aircraft and other asymmetric threats. The company's flagship product, ELECTROMAGNETIC PULSE, functions as a drone countermeasure by delivering multiple beams simultaneously, effectively disrupting and neutralizing aerial threats. Additionally, Epirus employs AI and computer vision to enhance its capabilities in detecting and tracking various targets of interest. Founded in 2018, Epirus aims to provide innovative solutions for both national security and commercial applications, optimizing power management and efficiency in electronic warfare scenarios.

Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer. The company was founded in 2019 and based in Durham, North Carolina.

Sift MediaSift Media is leveraging advanced AI and machine learning algorithms to hyper-target app install ads for its clients. They sift through 50 billion mobile ad requests daily, leveraging advanced AI & machine learning algorithms to hyper-target app install ads for our clients. To date, Sift has served 40B+ mobile ads and delivered 25M+ app installs for thousands of advertisers. In January 2016, Sift announced $3.25 million in funding led by Wakefield Group, with participation from Piedmont Capital, Alerion Ventures, IDEA Fund Partners, and several angel investors.